Cargando…
Single-Fraction Radiotherapy for CD30(+) Lymphoproliferative Disorders
Objectives. CD30(+) lymphoproliferative disorder is a rare variant of cutaneous T-cell lymphoma. Sustained complete response following first-line treatments is rare. This retrospective review evaluates the response of refractory or recurrent lesions to palliative radiation therapy. Methods. The reco...
Autores principales: | Gentile, Michelle S., Martinez-Escala, Maria Estela, Thomas, Tarita O., Guitart, Joan, Rosen, Steven, Kuzel, Timothy, Mittal, Bharat B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609348/ https://www.ncbi.nlm.nih.gov/pubmed/26504818 http://dx.doi.org/10.1155/2015/629587 |
Ejemplares similares
-
Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders
por: Abdulla, Farah R., et al.
Publicado: (2021) -
Methotrexate-induced CD30(+) T-cell lymphoproliferative disorder of the oral cavity
por: Saleh, Jamal Z., et al.
Publicado: (2016) -
Remittance of primary cutaneous CD30(+) lymphoproliferative disorder in a patient on adalimumab
por: Ottevanger, Rosanne, et al.
Publicado: (2022) -
CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies
por: Prieto-Torres, Lucia, et al.
Publicado: (2019) -
CD30-Positive T-Cell Lymphoproliferative Disease of the Oral Mucosa in Children: A Manifestation of Epstein-Barr Virus-Associated T-Lymphoproliferative Disorder
por: Hong, Mineui, et al.
Publicado: (2015)